These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6382991)

  • 1. Propranolol versus verapamil for the treatment of essential hypertension.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am Heart J; 1984 Sep; 108(3 Pt 1):554-60. PubMed ID: 6382991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium antagonism and beta-blockade on haemodynamic responses to stress.
    McInnes GT; Findlay IN; Murray GD; Dargie HJ
    Nephron; 1987; 47 Suppl 1():128-31. PubMed ID: 3320786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 24-hour ambulatory blood pressure profile with verapamil.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Circulation; 1982 Jan; 65(1):22-7. PubMed ID: 7053285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil and propranolol: a comparison of two antihypertensive agents.
    Leonetti G; Pasotti C; Ferrari GP; Zanchetti A
    Acta Med Scand Suppl; 1984; 681():137-41. PubMed ID: 6587752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
    McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
    J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of verapamil and propranolol on exercise tolerance in hypertensive patients.
    Mooy J; van Baak M; Böhm R; Does R; Petri H; van Kemenade J; Rahn KH
    Clin Pharmacol Ther; 1987 May; 41(5):490-5. PubMed ID: 3552358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic stable angina: comparison of verapamil and propranolol.
    Southall E; Nutt NR; Thomas RD
    J Int Med Res; 1982; 10(5):361-6. PubMed ID: 6754509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA; Chou TC; Lin KC
    J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
    Singh BN; Rebanal P; Piontek M; Nademanee K
    Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.
    Gould BA; Hornung RS; Mann S; Subramanian VB; Raftery EB
    Hypertension; 1983; 5(4 Pt 2):II91-6. PubMed ID: 6862589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.